Labshake search
Citations for R&D Systems :
701 - 750 of 4408 citations for Recombinant Human IIntercellular Adhesion Molecule 1 His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... Plates were incubated with PBSTBA diluted 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) for 2 h at RT ...
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Genomics 2024Quote: ... 5 mM beta-glycerophosphate and 1% insulin-transferrin-selenous acid (osteogenic media) and stimulated them the next day with recombinant human BMP2 (300 ng/ml) (R&D Systems, MN) in serum-free osteogenic media ...
-
bioRxiv - Systems Biology 2023Quote: Where indicated the cells were stimulated with the final concentration of 10 ng/ml of recombinant human TNF-α protein (R&D Systems) or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β ...
-
bioRxiv - Bioengineering 2020Quote: ... and 2.5 ng mL−1 recombinant mouse FGF2 (R&D Systems # 3139-FB-025). In some experiments ...
-
bioRxiv - Pathology 2021Quote: ... 1% Antibiotic-Antimycotic and 20ng/ml recombinant fibroblast growth factor 2 (R&D Systems)) and passaged using Accutase (Innovative Cell Technologies)19 ...
-
bioRxiv - Microbiology 2024Quote: ... In devices pre-treated with recombinant Ang-1 (923-AB-025, R&D Systems), pre-incubation occurred at 18-hours ...
-
bioRxiv - Synthetic Biology 2020Quote: ... Myc-tagged and V5-tagged CARs were stained using an Alexa Fluor 488-conjugated mouse anti-myc antibody (R&D Systems, IC3696G) and an Alexa Fluor 647-conjugated mouse anti-V5 antibody (Invitrogen ...
-
bioRxiv - Cell Biology 2020Quote: ... for 24 hours and rested overnight in C-RPMI with 100µM ferric ammonium citrate (FeAC) and 200U/ml of human recombinant IFN-γ (R&D Systems, MN USA) unless otherwise stated.
-
bioRxiv - Developmental Biology 2020Quote: Embryonic immortalised mouse epicardium-derived cells (mEPDC) were treated with 2.0 µg/ml human recombinant transforming growth factor (TGF)-β (R&D Systems; 240-B) for 30 hrs to induce EMT ...
-
bioRxiv - Developmental Biology 2019Quote: ... Both wild type and Adgrg6 KO ATDC5 cells were treated with 100ng/ml recombinant human IL-6 protein (rIL-6) (R&D System, 206-IL) for 2 hours before protein extraction.
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Human ACE2 Biotinylated Antibody (Cat # BAF933) and Recombinant Spike S1 RBD protein (Cat # NBP2-90982) were obtained from R&D Systems (Minneapolis, MN, 55413) and NOVUS Biologicals (Centennial ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Cancer Biology 2022Quote: ... +/-1 µg/mL anti-CD28 (CD28.2) antibody (eBioscience/Thermo 16-0289-81) or recombinant human CD58-Fc chimera protein (R&D Systems 10068-CD-050) at 37 ºC for 2 hours ...
-
bioRxiv - Bioengineering 2020Quote: ... Microvascular fragment-containing gels were cultured in serum-free media supplemented with 10 ng/mL recombinant human vascular endothelial growth factor (rhVEGF; R&D Systems, Minneapolis, MN) (55) ...
-
bioRxiv - Genetics 2020Quote: ... culture medium was replaced with KSR medium (Chambers et al., 2009, 2011) supplemented with 200 ng/ml of recombinant human Noggin (R&D Systems, Minneapolis, USA) and 10 μM of SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2021Quote: ... cells were starved for 5 hours in DermaLife Basal Medium followed by stimulation with human recombinant IL-17A (R&D systems, 50 ng/ml) and TNF-α (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... Five million PBMC were suspended in 40 ml R10 supplemented with 10 ng/ml recombinant human IL-2 (R&D Systems, 202-IL-050) together with 10 million K562-mbIL21-41BBL feeder cells irradiated with 100 Gy ...
-
bioRxiv - Neuroscience 2022Quote: ... a mix of 10 μg/mL Laminin and 5 μg/mL of each SLRP protein (recombinant human CHAD (R&D Systems Cat#8218-CH), FMOD (R&D Systems Cat#9840-FM) ...
-
bioRxiv - Physiology 2023Quote: ... 1nM) in VEH for 60 minutes prior to the addition of recombinant human TGF-β1 (5 ng/ml; R&D Systems, Minneapolis, MN, USA). At 6 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Experiments investigating EV-free AREG were undertaken by incubating recipient cells with 0.03 – 3000 ng/ml recombinant human Amphiregulin protein (R&D Systems #262-AR-100), for 30 minutes at 37°C before plating as described above.
-
bioRxiv - Molecular Biology 2023Quote: ... cells were maintained in serum-starved media with or without 10ng/ml of recombinant human TGF-β1 (R&D Systems, cat 240-B/CF) for 48 hours and harvested ...
-
bioRxiv - Bioengineering 2024Quote: ... Different concentrations of endogenous Cyr61 (0-200 ng/ml; Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN) and TGFβ (0 or 10 ng/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... foregut cells in the 24-well plate were cultured in DMEM base medium supplemented with 5 ng/mL recombinant human FGF basic/FGF2/bFGF (R&D systems; 233-FB), 10 ng/mL recombinant human VEGF-165 (Gibco ...
-
bioRxiv - Bioengineering 2024Quote: ... 0.1% v/v FBS with or without 100 ng/ml Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN). Medium change was performed at day 3 and images were taken at 3 and 5 days using a Keyence BZ-X800 Fluorescence Microscope (Keyence ...
-
bioRxiv - Bioengineering 2024Quote: Dye-labeled antimicrobial therapeutics (VHHα-(ABD)2-(EEG)6-Sx-POL-Cy7 or VHH16-ABD-(EEG)6-S17-PNT4-sulfo-Cy7) were incubated with recombinant human ADAM10 (R&D Systems, MN, U.S.A.) at 10 μM and 250 nM final concentrations respectively ...
-
bioRxiv - Bioengineering 2024Quote: ... foregut cells in the 24-well plate or on the pillar plate were cultured in advanced DMEM/F12 supplemented with 5 ng/mL recombinant human FGF basic/FGF2/bFGF (R&D systems; 233-FB), 10 ng/mL recombinant human VEGF-165 (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... Naïve T-cells were incubated in complete medium supplemented with 10 IU/mL recombinant human IL-2 (R&D Systems, 202-IL-050/CF). As a positive control ...
-
bioRxiv - Cancer Biology 2019Quote: ... Sheep anti-human-CD47 (1:100, R&D systems), Rat anti-mouse F4/80 (1:100 ...
-
bioRxiv - Microbiology 2021Quote: ... human type I IFN (R&D systems, 11415-1) was typically added at a final concentration of 150 U/ml ...
-
bioRxiv - Neuroscience 2020Quote: Human amyloid beta 1-40 (R&D Systems DAB140B) and 1-42 (R&D Systems DAB142 ...
-
bioRxiv - Bioengineering 2021Quote: ... Human TRA-1-85/CD147 (R&D systems, MAB3195), Cathepsin L (Santa Cruz Biotechnology ...
-
bioRxiv - Developmental Biology 2020Quote: ... anti-human NANOG (R&D Systems AF1997, 1:100), anti-TUJ1 (Novus Biologicals MAB1195 ...
-
bioRxiv - Cancer Biology 2019Quote: ... mouse-anti-human-FAP (R&D Systems, 1:50), and either mouse-anti-pan-Cytokeratin (Abcam ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10nM human gastrin I (R&D Systems, 3006/1), 500nM A83-01 (Selleckchem ...
-
bioRxiv - Neuroscience 2023Quote: ... anti-human Ku80 (goat; 1:500; R&D Systems), anti-Gnat1 (rabbit ...
-
bioRxiv - Immunology 2022Quote: ... Human ACE2 was detected using a polyclonal goat anti-human ACE2 antibody (1:500, R&D Systems), a horseradish peroxidase (HRP)-labeled donkey anti-goat antibody (1:5000 ...
-
bioRxiv - Cell Biology 2019Quote: ... Mouse anti-His primary antibody (R&D systems) was used at 1:1000 dilution in TBS ...
-
bioRxiv - Biochemistry 2020Quote: ... His-ubiquitin (R&D Systems; Cat. # U-530), HA-ubiquitin (R&D Systems ...
-
bioRxiv - Biochemistry 2020Quote: ... His-ubiquitin (R&D Systems; Cat. # U-530), HA-ubiquitin (R&D Systems ...
-
bioRxiv - Molecular Biology 2022Quote: ... His-HBP was purchased from R&D Systems. Purified His-HBP was incubated with beads bound with GST (control) ...
-
bioRxiv - Cell Biology 2023Quote: ... with 10% HI-FBS (R&D Systems S11150), 100x Pen/Strep (Gibco 15140-122) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and treated with recombinant Sonic Hedgehog 1 μg/ml (1845, R&D Systems, Minneapolis, MN) or vehicle control for 24 hours ...
-
bioRxiv - Developmental Biology 2023Quote: ... Chordin like-1 recombinant protein 0.4 μg/mL (R&D Systems 1808-NR-050/CF). For 2-DOG wash-out experiments ...
-
bioRxiv - Cell Biology 2023Quote: ... Recombinant mouse Follistatin-like 1 protein (rFSTL1, R&D systems, MN, #1738-FN, 100ng/ml) was added into the culture media 24 h after plating cells and incubated for 24 hrs ...
-
bioRxiv - Immunology 2021Quote: ... Mouse recombinant CXCL13 (R&D Systems) treatment was initiated one day after the tumor inoculation and administered intraperitoneally at 1 µg/mouse every other day for five times ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant TGF-β1 (R&D Systems), and RNASolv reagent (Omega Bio-Tek) ...